Daily Tech Roundup: Unigroup-Backed Chip Designer Valued at $9.1 Billion, Tencent-Backed AI Drug Researcher Kicks Off IPO
Listen to the full version
Welcome to the Daily Tech Roundup — a briefing of the top technology news making headlines in China and the rest of Asia.
Exclusive: Unigroup-backed phone chip designer valued at $9.1 billion
The latest funding round of Tsinghua Unigroup-backed mobile phone chip designer Unisoc will value it at about 66 billion yuan ($9.11 billion), falling short of its previous target, multiple sources told Caixin, adding that the company plans to start the listing process next year. Unisoc (Shanghai) Technologies Co. Ltd. is close to completing the more than 4 billion yuan funding round, the sources said. The latest financing adds to a 3.2 billion yuan syndicated loan that Unisoc obtained in March. The loan and the new investment should be able to sustain the company until its IPO, according to a person with knowledge of the matter.
Download our app to receive breaking news alerts and read the news on the go.
Get our weekly free Must-Read newsletter.
- RELATED
- DIGEST HUB
Digest Hub
Back
- Unisoc’s latest funding round values the company at $9.1 billion and includes a $3.2 billion loan, preparing it for an IPO next year.
- QuantumPharm aims to raise $145 million in a Hong Kong IPO, becoming the first pre-commercial tech company listing under a new regime, valuing it at over HK$17.1 billion.
- A coalition of over 400 Japanese companies plans to establish a $1 billion fund to enhance hydrogen supply chains, targeting economic security and cross-border investment.
- Tsinghua Unigroup
- Tsinghua Unigroup-backed Unisoc, a mobile phone chip designer, is nearing the completion of a funding round valued at approximately $9.11 billion. The company recently raised over 4 billion yuan and secured a 3.2 billion yuan syndicated loan in March to sustain operations until its planned IPO next year.
- Unisoc (Shanghai) Technologies Co. Ltd.
- Unisoc (Shanghai) Technologies Co. Ltd., a mobile phone chip designer backed by Tsinghua Unigroup, is valued at about 66 billion yuan ($9.11 billion) following a recent funding round. The company is close to completing a 4 billion yuan funding round and had secured a 3.2 billion yuan syndicated loan in March. Unisoc plans to start the listing process next year.
- QuantumPharm Inc.
- QuantumPharm Inc., an AI drug researcher backed by Tencent Holdings Ltd., aims to raise up to HK$1.13 billion ($145 million) in a Hong Kong IPO. The company will issue 187.37 million shares, priced between HK$5.03 and HK$6.03 each, valuing it at over HK$17.1 billion. Trading begins on June 13.
- Tencent Holdings Ltd.
- Tencent Holdings Ltd. is backing QuantumPharm Inc., an AI drug research company, which initiated an IPO in Hong Kong to raise $145 million. QuantumPharm, also known as XtalPi, is based in Shenzhen and became the first pre-commercial specialist technology company to list in Hong Kong under the new high-tech listings regime.
- GALLERY
- PODCAST
- MOST POPULAR
Sign in with Google
Sign in with Facebook
Sign in with 财新